Rebounding Malaria and the failures of eradication in Zanzibar: The World Health Organization campaign and the after effects, 1957-1985.

Global health ethics Malaria Malaria elimination Rebound malaria World Health Organization Zanzibar

Journal

Health & place
ISSN: 1873-2054
Titre abrégé: Health Place
Pays: England
ID NLM: 9510067

Informations de publication

Date de publication:
09 2022
Historique:
received: 20 09 2021
revised: 25 05 2022
accepted: 26 05 2022
pubmed: 25 6 2022
medline: 28 9 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

This article presents a case study of the WHO's malaria elimination attempt in Zanzibar and the decades after the program's conclusion in 1968. Drawing on archival, ethnographic, and interview data, we find that Zanzibar experienced a rebound malaria epidemic in the 1970s-1980s when prevalence rates surged higher than they were prior to the WHO's intervention. We show that scientists were aware of the risks of rebound before it happened and recognized the rebound epidemic as it was happening. We argue that many of the challenges facing Zanzibar in the 1960s remain dilemmas today, and many of the ethical questions about rebound malaria remain unaddressed.

Identifiants

pubmed: 35750573
pii: S1353-8292(22)00103-4
doi: 10.1016/j.healthplace.2022.102842
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

102842

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest We have no competing interests to declare.

Auteurs

Melissa Graboyes (M)

University of Oregon, Department of History, USA. Electronic address: graboyes@uoregon.edu.

Judith Meta (J)

Independent Scholar, Public Health Professional, Tanzania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH